Latest News of NUVA
Nuvalent, Inc. (NUVL) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
3 days ago
Nuvalent, a biopharmaceutical company, has initiated a public offering of $350 million of its Class A common stock to support its cancer-focused kinase therapies. The completion of the offering is sub...
Nuvalent Shares Gain on Cancer Drug Trial Updates
By MarketWatch |
3 days ago
Nuvalent's shares surged 20% in premarket trading after positive updates on its cancer drug programs. Phase 1 trials showed promising results for zidesamtinib and NVL-655, with Phase 2 trials progress...
Nuvalent, Inc. (NUVL): Among Hedge Funds' Top Biotech Stock Picks
By Yahoo! Finance |
5 days ago
The article discusses the risks and potential rewards of investing in biotechnology stocks, focusing on Nuvalent, Inc. (NASDAQ:NUVL). It highlights the importance of deep analysis, diversification, an...
-
Nuvalent, Inc. (NUVL): Short Seller Sentiment is Bearish on This Cancer Stock
By Yahoo! Finance | 5 days agoNuvalent, Inc. is a biopharmaceutical company focusing on developing targeted cancer therapies. Despite being ranked 4th on the list of worst cancer stocks by short sellers, Nuvalent has strong market...
-
Stocks Showing Market Leadership: Nuvalent Earns 91 RS Rating
By Investor's Business Daily | 1 week agoIBD's RS Rating helps identify a stock's technical performance on a scale of 1 to 99. Winning stocks often start with an RS Rating above 80. Nuvalent's stock is currently out of buy range....
-
Drew Afualo Is Engaged to Pili Tanuvasa: 'I Cried So Hard and for an Hour Straight'
By PEOPLE.com | 2 weeks agoThe host of The Comments Section podcast, 28, announced her engagement with her long-time partner, a fitness coach, on Instagram and TikTok. The couple shared heartfelt posts featuring the engagement ...
-
Stocks Showing Market Leadership: Nuvalent Earns 92 RS Rating
By Investor's Business Daily | 4 weeks agoLearn why institutional support is crucial for stock performance through IBD's rating system. Discover how to use stock charts effectively for profitable trading, including recognizing failed breakout...
-
Nuvalent doses first subject in Phase Ia/Ib trial of lung cancer treatment
By Yahoo! Finance | 1 month agoNuvalent, a US biopharmaceutical company, has initiated a Phase Ia/IIb trial of NVL-330, a HER2-selective inhibitor for HER2-altered non-small cell lung cancer....
-
We Think Nuvation Bio (NYSE:NUVB) Can Easily Afford To Drive Business Growth
By Yahoo! Finance | 2 months agoInvesting in unprofitable businesses like biotech and mining exploration can be lucrative, but many companies end up bankrupt due to cash burn. Nuvation Bio (NYSE:NUVB) has a cash runway of 9.3 years,...